Project Grant R01NS148919
- The National Institute of Neurological Disorders and Stroke awarded Northwestern University $230,985 on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a project examining alternative splicing of ion channels in the human brain. The project profiles the ion channel transcriptome and studies how alternative splicing affects neuronal physiology. Aim 1 combines long-read RNA sequencing and transcript capture technology...
- The National Institute of Neurological Disorders and Stroke awarded the University of California, San Diego $121,554 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Program Grant K99NS150832). The award funds research investigating pericyte regulation of central nervous system metabolism and function. The project tests hypotheses that pericytes regulate the CNS metabolome and thereby influence neurovascular...
- The National Institute of Neurological Disorders and Stroke awarded Northwestern University $440,000 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to characterize disease-associated KCNH1 mutations in human neurons. The research establishes cellular and molecular mechanisms by which heterozygous KCNH1 variants cause Templebaraitser Syndrome and Zimmermannlaband Syndrome, rare neurodevelopmental disorders marked by...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $589,156 on February 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project investigates s-palmitoylation as a regulatory mechanism for CAV2.1 and CAV2.2 calcium channels in presynaptic neurons. These channels mediate calcium influx that triggers neurotransmitter release at chemical synapses and...
- The National Institute of Neurological Disorders and Stroke awarded Rosalind Franklin University of Medicine & Science $396,015 on January 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support molecular characterization of genes regulating CAV2 voltage-gated calcium channels and their roles in channel trafficking and degradation. The research uses C. elegans as a model organism to identify and characterize genes...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $452,375 on August 10, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research to elucidate the molecular architecture and modulation of kainate receptor (KAR) complexes and their auxiliary proteins NETO1 and NETO2. The work combines high-resolution cryo-electron microscopy with...
- The National Institute of Neurological Disorders and Stroke awarded The Scripps Research Institute $710,155 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate post-transcriptional mechanisms of cortical inhibitory interneuron development. The research focuses on identifying how microRNA-mediated regulation controls interneuron migration and specification during development. The work employs engineered...
- The National Institute of Neurological Disorders and Stroke awarded The Regents of the University of California, San Francisco $595,208 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing Project Grant R01NS148534). The award funds research investigating striatal synaptic plasticity mechanisms underlying cognitive dysfunction in Parkinson's disease. The project examines circuit- and synaptic-level...
- The National Institute of Neurological Disorders and Stroke awarded $198,728 to The Trustees of Columbia University in the City of New York on March 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research quantifying relationships between behavior, neural network activity, and metabolic dysfunction in a genetic mouse model of developmental epileptic encephalopathy. The investigator will measure behavior and...
- The National Institute of Neurological Disorders and Stroke awarded New York University $550,743 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to fund research into the mechanisms of assembly of endocytic machinery at the periactive zone and its coupling to the presynaptic active zone. The research dissects how the large GTPase dynamin organizes both the active zone, where neurotransmitters are released from...
The National Institute of Neurological Disorders and Stroke awarded Sanford Burnham Prebys Medical Discovery Institute $670,380 on September 4, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to determine the stoichiometry of endogenous voltage-gated potassium channels in the brain. The research addresses fundamental gaps in understanding how ion channels are assembled and regulated in neurons. The work will elucidate the composition and arrangement of voltage-gated potassium (Kv) channel subunits in vivo under both physiological and pathological conditions, using a novel methodology developed by the principal investigator's laboratory. The research aims to identify how channel compositions are regulated by physiological stimuli or altered in disease states, and to determine whether disease-causing misassembled channels can be selectively targeted by therapeutics. The specific focus is on Kv1 family members, which control resting membrane potential and the firing pattern of action potentials in neurons. Performance occurs in La Jolla, California, with a period of performance from September 4, 2026, through August 31, 2031. The assistance type is a Project Grant, an investigator-initiated award supporting basic research into the structure and function of the nervous system that aligns with NINDS's mission to reduce the burden of neurological disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $670.4k | 9/3/26 |